Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BTB09089 (GPR65 agonist ) 是一种 T 细胞死亡相关基因 8 (TDAG8/GPR65) 特异性激动剂。BTB09089 诱导TDAG8 的表达,对 T 细胞和巨噬细胞细胞因子的产生进行调节。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 897 | 现货 | ||
5 mg | ¥ 2,150 | 现货 | ||
10 mg | ¥ 3,850 | 现货 | ||
25 mg | ¥ 6,190 | 现货 | ||
50 mg | ¥ 8,490 | 现货 | ||
100 mg | ¥ 11,300 | 现货 | ||
500 mg | ¥ 22,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,480 | 现货 |
产品描述 | BTB09089 (GPR65 agonist ) is a T cell death-associated gene 8 (TDAG8/GPR65)-specific agonist.BTB09089 induces TDAG8 expression and regulates cytokine production in T cells and macrophages. |
体外活性 |
BTB09089 (0-18 μM; 30 min) significantly increases the accumulation of cAMP in HEK293 cells transiently expressing hTDAG8 and mTDAG8, but does not exhibit a notable increase in control HEK293 cells. BTB09089 does not enhance the accumulation of cAMP in HEK293 cells expressing hGPR4 or the accumulation of inositol phosphates in HEK293 cells expressing hOGR1.[1]
BTB09089 (0-18 μM; 30 min) significantly enhances the accumulation of cAMP in a dose-dependent manner at pH 7.0-7.9, but not at pH 6.5.[1] BTB09089 (1-5 μM; 20 h) dose-dependently inhibits the production of IL-2 in WT mouse splenocytes, but does not inhibit IL-2 production in TDAG8 KO mice and does not affect cell viability.[1] BTB09089 (1-5 μM; 18 h) inhibits the production of TNF-α and IL-6 stimulated by LPS, while enhancing the production of IL-10 in peritoneal exudate cells (TG-PEC) induced by LPS stimulation with sulfated ester.[1] |
体内活性 | BTB09089 (5-20 μM, 8 μL; i.c.v.; administered 6 hours prior to MCAO) reduces cerebral ischemia-reperfusion injury in rats.[2] |
别名 | GPR65 agonist (BTB09089) |
分子量 | 387.31 |
分子式 | C14H12Cl2N4OS2 |
CAS No. | 245728-44-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.87 mg/mL (10 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5819 mL | 12.9096 mL | 25.8191 mL | 64.5478 mL |
5 mM | 0.5164 mL | 2.5819 mL | 5.1638 mL | 12.9096 mL | |
10 mM | 0.2582 mL | 1.291 mL | 2.5819 mL | 6.4548 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BTB09089 245728-44-3 DNA Damage/DNA Repair Endocrinology/Hormones GPCR/G Protein GPR DNA BTB 09089 GPR65 agonist GPR65 agonist (BTB09089) BTB-09089 Inhibitor inhibitor inhibit